2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid

Catalog No.: 
ACDWGT596
CAS No.: 
922516-08-3
Molecular Formula: 
C14H20N2O5
Molecular Weight: 
296.32
2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$262.00InquiryInquiry
100mg95%$382.00InquiryInquiry
250mg95%$539.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid
IUPAC Name2-(1-(tert-butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid
Molecular FormulaC14H20N2O5
Molecular Weight296.32
SMILESO=C(C1=COC(C2CCN(C(OC(C)(C)C)=O)CC2)=N1)O
InChI KeyUGZIVTFRKNAYGV-UHFFFAOYSA-N
Synonym2-{1-[(tert-Butoxy)carbonyl]piperidin-4-yl}-1,3-oxazole-4-carboxylic acid;2-(1-(tert-Butoxycarbonyl)piperidin-4-yl)oxazole-4-carboxylic acid;1-Piperidinecarboxylic acid, 4-(4-carboxy-2-oxazolyl)-, 1,1-dimethylethyl ester
CAS No.922516-08-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDWGT596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDWGT596 route product structure diagram
    ACDWGT596922516-08-3
Inquiry

2. ACDWGT596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDWGT596 route product structure diagram
    ACDWGT596922516-08-3
Inquiry

3. ACDWGT596 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACDWGT596 route product structure diagram
    ACDWGT596922516-08-3
Inquiry

Comments (0)